Life Sciences and Healthcare Regulatory partner Lincoln Tsang was featured in a recent The Pink Sheet article, "Pharma Firms Urged To Push For Post-Brexit Regulatory Equivalence Deal," which examines the ramifications of a post-Brexit regulatory equivalence agreement between the UK and EU on the pharmaceutical industry.
» Read the full article (subscription required).
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
